Navigation Links
Mayo Clinic Proceedings article explores possible link between obesity and viral infections
Date:10/23/2007

xposure to the Ad-36 virus in humans. Dr. Atkinsons study screened for antibodies to Ad-36 (a sign of exposure to this virus) in 502 people of varying body weights, both obese and non-obese, from three cities in the United States. Ad-36 antibodies were found in 30 percent of obese individuals and 11 percent of lean individuals. Study results also showed highly significant differences in body mass index (BMI) between antibody-positive and antibody-negative individuals.

Dr. Atkinson also highlighted a study that looked at 89 sets of American adult twins and screened them for Ad-36. Because twins tend to be similar in many characteristics, including body weight, the researchers looked at twin pairs where one twin tested positively for Ad-36 and the other did not.

Antibody-positive twins were slightly, but significantly, heavier and fatter than their antibody negative co-twins, says Dr. Atkinson. The infected twins had a higher BMI and a greater percent of body fat than the uninfected co-twins.

In the mid-1970s, a virus called SMAM-1 was believed responsible for an increased death rate among commercially raised chickens in India. SMAM-1 is associated with decreased immune function and an increased accumulation of body fat in infected chickens. Dr. Atkinson reports that one study tested 52 obese humans for antibodies to SMAM-1. About 20 percent had SMAM-1 antibodies, indicating exposure to this virus. The study participants who had these antibodies were heavier and had a higher body mass index compared with the antibody-negative group.

Dr. Atkinsons article also explores what current research has to say about the possible mechanisms underlying virus-induced obesity. Some research suggests that viral infections have a direct effect on adipocytes, cells that manufacture and store fat, turning on the enzymes of fat accumulation and recruitment of new adipocytes.

Whats the next step for this research? According to Dr. Atkinson,
'/>"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. How do patients benefit of clinical trials
3. Magnetic resonance angiography in clinical medicine
4. Clinical trials need to be more frank
5. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
6. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
7. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
8. Clinical Comparisons Between ADHD Drugs Are Less
9. Specialized Clinics For Manipurs AIDS Patients
10. Outsourcing clinical trials to India
11. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... prescription drugs with hydrocodone could be involved , , ... announced Friday a crackdown on drug companies that make ... used as a cough suppressant and pain killer. ... to treat pain or to suppress cough. It,s also ...
... ... Percent Revenue Growth, ATLANTA, Sept. 28 For the third year ... has been named to Deloitte,s prestigious Technology Fast,50 program for Georgia. SecureWorks ... and has ranked in the top ten,for the past three years. ...
... the lives of patients who have suffered a stroke and ... on bmj.com today. , Stroke is the second ... cause of serious, long-term disability in adults. Six months ... others to help them carry out everyday tasks such as ...
... unveiled plans for a $100 million initiative to create ... problems in the developing world, such as HIV/AIDS and ... annual meeting of the Clinton Global Initiative in New ... Health," the initiative will focus on both research and ...
... LLC, a clinical-stage drug development company,commercializing first-in-class drugs ... diffusion, today announced the results of a Phase ... sodium crocetinate (TSC). In,addition, the company announced the ... of which will support the company,s overall growth,and ...
... accompanies the condition, study finds , , FRIDAY, Sept. ... whose painful illness prompts depression, relief may come ... embraced by millions around the world: meditation. , ... techniques helped patients shave as much as one-third ...
Other Medicine News:Health News:FDA Cracks Down on Unapproved Cough Medicines 2Health News:FDA Cracks Down on Unapproved Cough Medicines 3Health News:FDA Cracks Down on Unapproved Cough Medicines 4Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 2Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 3Health News:SecureWorks Ranked 6th in Deloitte's Technology Fast 50 Program for Georgia 4Health News:Rice unveils $100 million initiative for world health technology 2Health News:Rice unveils $100 million initiative for world health technology 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4Health News:Meditation May Help Rheumatoid Arthritis Sufferers 2Health News:Meditation May Help Rheumatoid Arthritis Sufferers 3Health News:Meditation May Help Rheumatoid Arthritis Sufferers 4
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... Fisher,Scientific Inc. (NYSE: TMO ), the world ... U.S. Food and Drug Administration (FDA) clearance for,Spectra(TM) ... aureus (MRSA), more commonly known as the "superbug." ... MRSA,screening, Spectra provides accurate results within 24 hours. ...
... Merck to Conduct Preclinical Proof-of-Principle Studies -, ... IOMI ) today announced that it has ... conduct proof-of-principle preclinical studies,evaluating the use of the ... option to negotiate an exclusive license. These,preclinical proof-of-principle ...
Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Steroid eluting pacemaker leads...
The Medtronic Model 6495 bipolar coaxial temporary pacing lead is designed to provide the advantages of bipolar technology based on the sensing and pacing capabilities of the Medtronic Model 6500 uni...
Medicine Products: